Comment by tvural

I would also point out that short sellers and "activist investors" are a significant downside to being public. Essentially you give investors focused on these strategies a financial incentive to destroy the company's long-term value. Activism has been a big problem for drug companies where investors will try to fire all the scientists so that profits will go up for a few years.